The Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant markups. Justices Vikram Nath and SVN Bhatti criticized pharma companies for neglecting the struggles of ordinary people. They urged the government to consider a uniform pricing rule that limits maximum retail prices. The court highlighted the burden on taxpayers due to inflated medical expenses reimbursed under public health schemes.